Klobuchar, Heinrich, Merkley, Colleagues Raise Concerns About National Trail Program
WASHINGTON – Senator Amy Klobuchar (D-MN), Ranking Member of the Senate Committee on Agriculture, Nutrition, and Forestry, and Martin Heinrich (D-NM), Ranking Member of the Senate Committee on Energy and Natural Resources, and Jeff Merkley (D-OR), Ranking Member of the Senate Appropriations Subcommittee on Interior, Environment, and Related Agencies are
Merkley, Wyden, Colleagues Release Report of How Private Student Loan Lenders Expect to Profit from Trump’s Big Ugly Bill
Report: “Costly Consequences: How the Trump Administration Unleashed Private Student Loan Lenders” (PDF) Responses from: Citizens | College Ave | Navient | Nelnet | Sallie Mae | SoFi Washington, D.C. – Oregon’s U.S. Senators Jeff Merkley and Ron Wyden joined a group of Senators in releasing a new report of their investigation into how private student loan lenders will reap the
Senate Foreign Relations Democrats Statement on Reports of Trump Family Bribe from UAE Officials
WASHINGTON – Today, U.S. Senators Jeanne Shaheen, Ranking Member of the Senate Foreign Relations Committee, Chris Coons (D-DE), Chris Murphy (D-CT), Tim Kaine (D-VA), Jeff Merkley (D-OR), Cory Booker (D-NJ), Brian Schatz (D-HI), Chris Van Hollen (D-MD), Tammy Duckworth (D-IL) and Jacky Rosen (D-NV) released the following statement in response to reporting that a company backed by
Wyden, Merkley, Colleagues Press Walgreens, Put National Pharmacies on Notice to Ensure Mifepristone Access
Washington, D.C. – U.S. Senators Ron Wyden and Jeff Merkley today announced they have joined colleagues in urging seven of the nation’s largest retail pharmacies to provide the strongest possible legal access to mifepristone for patients—and communicate clearly about their plans and policies. In the letters sent this week to Walgreens,
Merkley Joins Push to Crack Down on Pharmaceutical Greed, Cap Price of Insulin
Washington, D.C. – Oregon’s U.S. Senator Jeff Merkley joined colleagues in both chambers of Congress to introduce bicameral legislation that would cap the list price of insulin at no more than $20 per vial. The Insulin for All Act of 2023 would substantially reduce the cost of this lifesaving drug
Merkley: President’s Budget Proposal Opens Doors of Opportunity; Builds on Successes
WASHINGTON, D.C. – Today, Oregon’s U.S. Senator Jeff Merkley issued the following statement after President Joe Biden released his administration’s budget proposal for Fiscal Year 2024: “This budget is a strong blueprint for opening doors of opportunity to everyone – no matter where they live, what they look like, or
Wyden, Merkley, Colleagues Introduce Legislation to Restore and Protect Abortion Rights Nationwide
Washington, D.C. – U.S. Senators Ron Wyden and Jeff Merkley today joined colleagues to introduce federal legislation that would guarantee access to abortion, everywhere across the country and restore the right to comprehensive reproductive health care for millions of Americans. “We must pass the Women’s Health Protection Act and enshrine abortion rights
Merkley Grills Norfolk Southern CEO Over Safety at Senate Hearing
WASHINGTON, D.C. – Today, Oregon’s U.S. Senator Jeff Merkley – the Chairman of the Subcommittee on Chemical Safety, Waste Management, Environmental Justice, and Regulatory Oversight on the Committee on Environment and Public Works – pressed Alan Shaw, the CEO of Norfolk Southern, to commit to safety improvements before engaging in
NEWS: Following Successful Public Pressure Campaign to Lower the Cost of Eli Lilly’s Insulin, Sanders and Bush Introduce Bill to Finish the Job and Cap the Price at $20 Per Vial
WASHINGTON, March 9 – Sen. Bernie Sanders (I-Vt.), chairman of the Senate Health, Education, Labor, and Pensions Committee, and Rep. Cori Bush (D-Mo.) on Thursday introduced legislation that would cap the list price of insulin at no more than $20 per vial, substantially reducing the cost of the lifesaving drug
English 
Spanish